Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia

In pediatric acute myeloid leukemia (AML), fusions involving lysine methyltransferase 2A (KMT2A) are considered hallmarks of aggressive AML, for whom the development of targeted specific therapeutic agents to ameliorate classic chemotherapy and obtain a complete eradication of disease is urgent. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Tregnago, Claudia, Benetton, Maddalena, Da Ros, Ambra, Borella, Giulia, Longo, Giorgia, Polato, Katia, Francescato, Samuela, Biffi, Alessandra, Pigazzi, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830338/
https://www.ncbi.nlm.nih.gov/pubmed/35153769
http://dx.doi.org/10.3389/fphar.2021.820191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830338/
https://www.ncbi.nlm.nih.gov/pubmed/35153769
http://dx.doi.org/10.3389/fphar.2021.820191

Ejemplares similares